Lactose (India) Ltd Falls 14.76%: Margin Pressures and Profit Decline Drive Weekly Slide
2026-11-21 17:06:30Key Events This Week 16 Nov: Sharp quarterly profit decline reported amid margin compression 16 Nov: Stock plunges 16.29% on heavy selling pressure 17 Nov: Partial recovery with 4.58% gain following market rebound 18 Nov: Profit-taking leads to 4.54% drop amid Sensex weakness 19 Nov: Modest 0.92% rise as market sentiment improves 20 Nov: Week closes with 1.08% gain but overall weekly loss remains steep ...
Read More
Lactose (India) Ltd is Rated Sell by MarketsMOJO
2026-11-19 10:10:04Lactose (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Lactose (India) Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Margin Pressures
2026-11-16 12:00:16Lactose (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a notable shift in its financial trend for the quarter ended September 2026. Despite achieving record quarterly net sales, the company’s profitability metrics have deteriorated sharply, prompting a downgrade in its Mojo Grade from Buy to Hold. This article analyses the recent quarterly performance in the context of historical trends and broader market movements.
Read More
Lactose (India) Ltd is Rated Buy by MarketsMOJO
2026-11-04 10:11:29Lactose (India) Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 28 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Lactose (India) Ltd is Rated Hold by MarketsMOJO
2026-10-23 10:10:18Lactose (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Lactose (India) Ltd is Rated Hold by MarketsMOJO
2026-10-12 10:11:05Lactose (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreLactose (India) Ltd Falls 6.31%: 3 Key Factors Driving the Weekly Decline
2026-10-03 17:03:29Key Events This Week 28 Sep: Upgrade to Buy on strong technical and valuation improvements 30 Sep: Valuation shifts signal enhanced price attractiveness 1 Oct: Downgrade to Hold amid mixed technical and valuation signals 2 Oct: No trading data available; week closes at Rs.105.40 (-6.31%) Week OpenRs.112.50 Week Close<...
Read More
Lactose (India) Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-10-01 08:02:33Lactose (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 30 September 2026. This adjustment reflects a nuanced reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. While the company continues to demonstrate robust long-term growth and attractive valuation metrics relative to peers, evolving technical indicators and certain risk factors have prompted a more cautious stance.
Read More
Lactose (India) Ltd Valuation Shifts Signal Enhanced Price Attractiveness
2026-09-30 08:00:20Lactose (India) Ltd has witnessed a significant improvement in its valuation parameters, prompting an upgrade in its investment grade from Hold to Buy. With its price-to-earnings (P/E) ratio and price-to-book value (P/BV) now classified as very attractive relative to peers and historical averages, the micro-cap pharmaceutical player is drawing renewed investor interest despite a modest day decline of 1.5%.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSEPursuant to Regulation 30 and 47(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) we hereby submit the news paper publication if the Un-audited financial results for the Second Quarter and Half Year Ended as on 30th September 2026
Regulation 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Un-Audited Financial Results For The Second Quarter And Half Year Ended 30Th September 2026
14-Nov-2026 | Source : BSEBoard Meeting Outcome for Outcome Of Board Meeting Held On Saturday 14Th November 2026
14-Nov-2026 | Source : BSECorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available